KEY FINDINGS Asia-Pacific Single cell analysis market is estimated to grow at a CAGR of 20.12 % for the forecast year of 2017-2025 and is anticipated to generate a revenue of about $1530 million by the year 2025. Asia Pacific is anticipated to be the fastest growing market during the forecast period because of the increasing technological advancement and booming biotechnology and biopharmaceutical industries.
MARKET INSIGHTS The Asia-Pacific market geography consists of countries like India, China, Australia, Japan and the Rest of Asia Pacific. The market potential in the Asia-Pacific region is mainly a result of a developing need for stem cell therapies for the treatment owing to increasing number of patient population and prevalence of chronic lifestyle diseases. An increase in the government funding for research, rising potential in single-cell DNA and RNA analysis and increasing occurrence of infectious diseases are the major factors contributing to the growth of the market.
COMPETITIVE INSIGHTS The major players in the Single-cell analysis market are Thermo Fisher Scientific Inc, GE Healthcare, Beckman colter Inc, Beckton Dickinson and company, Stem Cell Technologies, Stryker Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, Nanostring Technologies Inc, and Agilent Technology Inc. GE Healthcare has the major market share in the single cell market as compared to rest of the companies.
Our reports have been used by over 10K customers, including:
The global single-use assemblies market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period. The growth of the single-use assemblies market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies,...
Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule...
“Axial spondyloarthritis - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Axial spondyloarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...
306 pages •
By Global Industry Analysts
• May 2021
Global Cell Harvesting Market to Reach $359.2 Million by 2026
Cell harvesting is a next-generation technique that involves collection of stem cells from the culture media for R&D and therapeutic applications. Growth in the global market is spurred by of increasing investments...
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination,...
The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period. The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. Moreover, the growth opportunities...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.